Skip to main content
Erschienen in: Annals of Surgical Oncology 4/2013

01.04.2013 | Gastrointestinal Oncology

Gastrectomy for Early Gastric Cancer is Associated with Decreased Cardiovascular Mortality in Association with Postsurgical Metabolic Changes

verfasst von: Yong-ho Lee, MD, Seung Jin Han, MD, PhD, Hyeon Chang Kim, MD, PhD, Woo Jin Hyung, MD, PhD, Joon Seok Lim, MD, PhD, Kwangsuk Lee, MD, Hyun Joo Lee, MD, Eun Young Lee, MD, Eun Seok Kang, MD, PhD, Chul Woo Ahn, MD, PhD, Bong Soo Cha, MD, PhD, Hyun Chul Lee, MD, PhD

Erschienen in: Annals of Surgical Oncology | Ausgabe 4/2013

Einloggen, um Zugang zu erhalten

Abstract

Background

Bariatric surgery effectively induces weight loss and resolves cardiovascular comorbidities in obese patients. We investigated cardiovascular and all-cause mortality in patients who underwent gastrectomies for early gastric cancer (EGC) and analyzed the changes in metabolic parameters after surgery.

Methods

A total of 2,477 patients who underwent gastrectomies for EGC between 1995 and 2004 were enrolled in the study and followed for mortality through 2007. Standardized mortality ratios (SMRs) were calculated using sex- and age-matched mortality in the general Korean population in 2005. Effects of gastrectomy on changes in body weight and metabolic parameters were investigated in 51 of the patients before and after surgery.

Results

During the 15,096.4 person-years of follow-up, 244 deaths were recorded. The all-cause mortality was not significantly different from that of the general population (SMR [95 % confidence interval (CI)] = 1.01 [0.89 − 1.14]); however, cardiovascular mortality was significantly lower (SMR = 0.35 [0.22 − 0.53]). In the 51 patients included in the second part of the study, significant reductions in body weight and visceral fat areas occurred after surgery, regardless of whether the patients were previously obese. Triglycerides, LDL-cholesterol, and plasminogen activator inhibitor-1 levels were significantly decreased, whereas HDL-cholesterol and adiponectin levels were increased. Carotid intima-media thickness also was significantly decreased in previously obese and nonobese patients.

Conclusions

Patients with EGC who undergo gastrectomy have a lower cardiovascular mortality but similar all-cause mortality as that of the general population. In these patients, a significant reduction in body weight and visceral fat after surgery may improve impaired lipid metabolism and prevent atherosclerotic changes.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Tice JA, Karliner L, Walsh J, Petersen AJ, Feldman MD. Gastric banding or bypass? A systematic review comparing the two most popular bariatric procedures. Am J Med. 2008;121:885–93.PubMedCrossRef Tice JA, Karliner L, Walsh J, Petersen AJ, Feldman MD. Gastric banding or bypass? A systematic review comparing the two most popular bariatric procedures. Am J Med. 2008;121:885–93.PubMedCrossRef
2.
Zurück zum Zitat Adams TD, Gress RE, Smith SC, et al. Long-term mortality after gastric bypass surgery. N Engl J Med. 2007;357:753–61.PubMedCrossRef Adams TD, Gress RE, Smith SC, et al. Long-term mortality after gastric bypass surgery. N Engl J Med. 2007;357:753–61.PubMedCrossRef
3.
Zurück zum Zitat Yang J, Li C, Liu H, Gu H, Chen P, Liu B. Effects of subtotal gastrectomy and Roux-en-Y gastrojejunostomy on the clinical outcome of type 2 diabetes mellitus. J Surg Res. 2010;164:e67–71.PubMedCrossRef Yang J, Li C, Liu H, Gu H, Chen P, Liu B. Effects of subtotal gastrectomy and Roux-en-Y gastrojejunostomy on the clinical outcome of type 2 diabetes mellitus. J Surg Res. 2010;164:e67–71.PubMedCrossRef
4.
Zurück zum Zitat von Holstein CS. Long-term prognosis after partial gastrectomy for gastroduodenal ulcer. World J Surg. 2000;24:307–14.CrossRef von Holstein CS. Long-term prognosis after partial gastrectomy for gastroduodenal ulcer. World J Surg. 2000;24:307–14.CrossRef
5.
Zurück zum Zitat Stael von Holstein C, Anderson H, Ahsberg K, Huldt B. The significance of ulcer disease on late mortality after partial gastric resection. Eur J Gastroenterol Hepatol. 1997;9:33–40.PubMedCrossRef Stael von Holstein C, Anderson H, Ahsberg K, Huldt B. The significance of ulcer disease on late mortality after partial gastric resection. Eur J Gastroenterol Hepatol. 1997;9:33–40.PubMedCrossRef
6.
Zurück zum Zitat Macintyre IM, O’Brien F. Death from malignant disease after surgery for duodenal ulcer. Gut. 1994;35:451–4.PubMedCrossRef Macintyre IM, O’Brien F. Death from malignant disease after surgery for duodenal ulcer. Gut. 1994;35:451–4.PubMedCrossRef
7.
Zurück zum Zitat Japanese Gastric Cancer A. Japanese classification of gastric carcinoma, 2nd English edn. Gastric Cancer. 1998;1:10–24.CrossRef Japanese Gastric Cancer A. Japanese classification of gastric carcinoma, 2nd English edn. Gastric Cancer. 1998;1:10–24.CrossRef
8.
Zurück zum Zitat Goodpaster BH. Measuring body fat distribution and content in humans. Curr Opin Clin Nutr Metab Care. 2002;5:481–7.PubMedCrossRef Goodpaster BH. Measuring body fat distribution and content in humans. Curr Opin Clin Nutr Metab Care. 2002;5:481–7.PubMedCrossRef
9.
Zurück zum Zitat Haugnes HS, Wethal T, Aass N, et al. Cardiovascular risk factors and morbidity in long-term survivors of testicular cancer: a 20-year follow-up study. J Clin Oncol. 2010;28:4649–57.PubMedCrossRef Haugnes HS, Wethal T, Aass N, et al. Cardiovascular risk factors and morbidity in long-term survivors of testicular cancer: a 20-year follow-up study. J Clin Oncol. 2010;28:4649–57.PubMedCrossRef
10.
Zurück zum Zitat Hooning MJ, Botma A, Aleman BM, et al. Long-term risk of cardiovascular disease in 10-year survivors of breast cancer. J Natl Cancer Inst. 2007;99:365–75.PubMedCrossRef Hooning MJ, Botma A, Aleman BM, et al. Long-term risk of cardiovascular disease in 10-year survivors of breast cancer. J Natl Cancer Inst. 2007;99:365–75.PubMedCrossRef
11.
Zurück zum Zitat Aro J. Cardiovascular and all-cause mortality in prostatic cancer patients treated with estrogens or orchiectomy as compared to the standard population. Prostate. 1991;18:131–7.PubMedCrossRef Aro J. Cardiovascular and all-cause mortality in prostatic cancer patients treated with estrogens or orchiectomy as compared to the standard population. Prostate. 1991;18:131–7.PubMedCrossRef
12.
Zurück zum Zitat Kim H, Ahn S. The current status and future perspectives of laparoscopic surgery for gastric cancer. J Korean Surg Soc. 2011;81:151–62.PubMedCrossRef Kim H, Ahn S. The current status and future perspectives of laparoscopic surgery for gastric cancer. J Korean Surg Soc. 2011;81:151–62.PubMedCrossRef
13.
Zurück zum Zitat Nomura S, Kaminishi M. Surgical treatment of early gastric cancer. Dig Surg. 2007;24:96–100.PubMedCrossRef Nomura S, Kaminishi M. Surgical treatment of early gastric cancer. Dig Surg. 2007;24:96–100.PubMedCrossRef
14.
Zurück zum Zitat Liedman B, Andersson H, Bosaeus I, Hugosson I, Lundell L. Changes in body composition after gastrectomy: results of a controlled, prospective clinical trial. World J Surg. 1997;21:416–21.PubMedCrossRef Liedman B, Andersson H, Bosaeus I, Hugosson I, Lundell L. Changes in body composition after gastrectomy: results of a controlled, prospective clinical trial. World J Surg. 1997;21:416–21.PubMedCrossRef
15.
Zurück zum Zitat Zhang F, Strain GW, Lei W, Dakin GF, Gagner M, Pomp A. Changes in lipid profiles in morbidly obese patients after laparoscopic sleeve gastrectomy (LSG). Obes Surg. 2011;21:305–9.PubMedCrossRef Zhang F, Strain GW, Lei W, Dakin GF, Gagner M, Pomp A. Changes in lipid profiles in morbidly obese patients after laparoscopic sleeve gastrectomy (LSG). Obes Surg. 2011;21:305–9.PubMedCrossRef
16.
Zurück zum Zitat Mingrone G, Castagneto-Gissey L. Mechanisms of early improvement/resolution of type 2 diabetes after bariatric surgery. Diabetes Metab. 2009;35:518–23.PubMedCrossRef Mingrone G, Castagneto-Gissey L. Mechanisms of early improvement/resolution of type 2 diabetes after bariatric surgery. Diabetes Metab. 2009;35:518–23.PubMedCrossRef
17.
Zurück zum Zitat Rieu PN, Jansen JB, Joosten HJ, Lamers CB. Effect of gastrectomy with either Roux-en-Y or Billroth II anastomosis on small-intestinal function. Scand J Gastroenterol. 1990;25:185–92.PubMedCrossRef Rieu PN, Jansen JB, Joosten HJ, Lamers CB. Effect of gastrectomy with either Roux-en-Y or Billroth II anastomosis on small-intestinal function. Scand J Gastroenterol. 1990;25:185–92.PubMedCrossRef
18.
Zurück zum Zitat Glober GA, Rhoads GG, Liu F, Kagan A. Long-term results of gastrectomy with respect to blood lipids, blood pressure, weight and living habits. Ann Surg. 1974;179:896–901.PubMedCrossRef Glober GA, Rhoads GG, Liu F, Kagan A. Long-term results of gastrectomy with respect to blood lipids, blood pressure, weight and living habits. Ann Surg. 1974;179:896–901.PubMedCrossRef
19.
Zurück zum Zitat Jeon TY, Lee S, Kim HH, Kim YJ, Lee JG, Jeong DW. Long-term changes in gut hormones, appetite and food intake 1 year after subtotal gastrectomy with normal body weight. Eur J Clin Nutr. 2010;64:826–31.PubMedCrossRef Jeon TY, Lee S, Kim HH, Kim YJ, Lee JG, Jeong DW. Long-term changes in gut hormones, appetite and food intake 1 year after subtotal gastrectomy with normal body weight. Eur J Clin Nutr. 2010;64:826–31.PubMedCrossRef
20.
Zurück zum Zitat Lee YH, Lee SH, Jung ES, et al. Visceral adiposity and the severity of coronary artery disease in middle-aged subjects with normal waist circumference and its relation with lipocalin-2 and MCP-1. Atherosclerosis. 2010;213:592–7.PubMedCrossRef Lee YH, Lee SH, Jung ES, et al. Visceral adiposity and the severity of coronary artery disease in middle-aged subjects with normal waist circumference and its relation with lipocalin-2 and MCP-1. Atherosclerosis. 2010;213:592–7.PubMedCrossRef
21.
Zurück zum Zitat Antuna-Puente B, Feve B, Fellahi S, Bastard JP. Adipokines: the missing link between insulin resistance and obesity. Diabetes Metab. 2008;34:2–11.PubMedCrossRef Antuna-Puente B, Feve B, Fellahi S, Bastard JP. Adipokines: the missing link between insulin resistance and obesity. Diabetes Metab. 2008;34:2–11.PubMedCrossRef
22.
Zurück zum Zitat Kopp HP, Krzyzanowska K, Mohlig M, Spranger J, Pfeiffer AF, Schernthaner G. Effects of marked weight loss on plasma levels of adiponectin, markers of chronic subclinical inflammation and insulin resistance in morbidly obese women. Int J Obes (Lond). 2005;29:766–71.CrossRef Kopp HP, Krzyzanowska K, Mohlig M, Spranger J, Pfeiffer AF, Schernthaner G. Effects of marked weight loss on plasma levels of adiponectin, markers of chronic subclinical inflammation and insulin resistance in morbidly obese women. Int J Obes (Lond). 2005;29:766–71.CrossRef
23.
Zurück zum Zitat Skurk T, Hauner H. Obesity and impaired fibrinolysis: role of adipose production of plasminogen activator inhibitor-1. Int J Obes Relat Metab Disord. 2004;28:1357–64.PubMedCrossRef Skurk T, Hauner H. Obesity and impaired fibrinolysis: role of adipose production of plasminogen activator inhibitor-1. Int J Obes Relat Metab Disord. 2004;28:1357–64.PubMedCrossRef
24.
Zurück zum Zitat Eriksson P, Reynisdottir S, Lonnqvist F, Stemme V, Hamsten A, Arner P. Adipose tissue secretion of plasminogen activator inhibitor-1 in non-obese and obese individuals. Diabetologia. 1998;41:65–71.PubMedCrossRef Eriksson P, Reynisdottir S, Lonnqvist F, Stemme V, Hamsten A, Arner P. Adipose tissue secretion of plasminogen activator inhibitor-1 in non-obese and obese individuals. Diabetologia. 1998;41:65–71.PubMedCrossRef
25.
Zurück zum Zitat Cesari M, Pahor M, Incalzi RA. Plasminogen activator inhibitor-1 (PAI-1): a key factor linking fibrinolysis and age-related subclinical and clinical conditions. Cardiovasc Ther. 2010;28:e72–e91.PubMedCrossRef Cesari M, Pahor M, Incalzi RA. Plasminogen activator inhibitor-1 (PAI-1): a key factor linking fibrinolysis and age-related subclinical and clinical conditions. Cardiovasc Ther. 2010;28:e72–e91.PubMedCrossRef
26.
Zurück zum Zitat Estelles A, Dalmau J, Falco C, Berbel O, Castello R, Espana F, Aznar J. Plasma PAI-1 levels in obese children–effect of weight loss and influence of PAI-1 promoter 4G/5G genotype. Thromb Haemost. 2001;86:647–52.PubMed Estelles A, Dalmau J, Falco C, Berbel O, Castello R, Espana F, Aznar J. Plasma PAI-1 levels in obese children–effect of weight loss and influence of PAI-1 promoter 4G/5G genotype. Thromb Haemost. 2001;86:647–52.PubMed
27.
Zurück zum Zitat Collet JP, Montalescot G, Vicaut E, et al. Acute release of plasminogen activator inhibitor-1 in ST-segment elevation myocardial infarction predicts mortality. Circulation. 2003;108:391–4.PubMedCrossRef Collet JP, Montalescot G, Vicaut E, et al. Acute release of plasminogen activator inhibitor-1 in ST-segment elevation myocardial infarction predicts mortality. Circulation. 2003;108:391–4.PubMedCrossRef
28.
Zurück zum Zitat Juhan-Vague I, Pyke SD, Alessi MC, Jespersen J, Haverkate F, Thompson SG. Fibrinolytic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. ECAT Study Group. European Concerted Action on Thrombosis and Disabilities. Circulation. 1996;94:2057–63.PubMedCrossRef Juhan-Vague I, Pyke SD, Alessi MC, Jespersen J, Haverkate F, Thompson SG. Fibrinolytic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. ECAT Study Group. European Concerted Action on Thrombosis and Disabilities. Circulation. 1996;94:2057–63.PubMedCrossRef
29.
Zurück zum Zitat Simon A, Gariepy J, Chironi G, Megnien J, Levenson J. Intima-media thickness: a new tool for diagnosis and treatment of cardiovascular risk. J Hypertens. 2002;20:159–69.PubMedCrossRef Simon A, Gariepy J, Chironi G, Megnien J, Levenson J. Intima-media thickness: a new tool for diagnosis and treatment of cardiovascular risk. J Hypertens. 2002;20:159–69.PubMedCrossRef
30.
Zurück zum Zitat Habib P, Scrocco JD, Terek M, Vanek V, Mikolich JR. Effects of bariatric surgery on inflammatory, functional and structural markers of coronary atherosclerosis. Am J Cardiol. 2009;104:1251–5.PubMedCrossRef Habib P, Scrocco JD, Terek M, Vanek V, Mikolich JR. Effects of bariatric surgery on inflammatory, functional and structural markers of coronary atherosclerosis. Am J Cardiol. 2009;104:1251–5.PubMedCrossRef
31.
Zurück zum Zitat Won T, Kang B, Im T, Choi H. The study of accuracy of death statistics. J Korean Soc Emerg Med. 2007;18:256–62. Won T, Kang B, Im T, Choi H. The study of accuracy of death statistics. J Korean Soc Emerg Med. 2007;18:256–62.
Metadaten
Titel
Gastrectomy for Early Gastric Cancer is Associated with Decreased Cardiovascular Mortality in Association with Postsurgical Metabolic Changes
verfasst von
Yong-ho Lee, MD
Seung Jin Han, MD, PhD
Hyeon Chang Kim, MD, PhD
Woo Jin Hyung, MD, PhD
Joon Seok Lim, MD, PhD
Kwangsuk Lee, MD
Hyun Joo Lee, MD
Eun Young Lee, MD
Eun Seok Kang, MD, PhD
Chul Woo Ahn, MD, PhD
Bong Soo Cha, MD, PhD
Hyun Chul Lee, MD, PhD
Publikationsdatum
01.04.2013
Verlag
Springer-Verlag
Erschienen in
Annals of Surgical Oncology / Ausgabe 4/2013
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-012-2688-5

Weitere Artikel der Ausgabe 4/2013

Annals of Surgical Oncology 4/2013 Zur Ausgabe

Regional Cancer Therapies

Regional Therapies for Cancer

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.